Zhu Kai, Dong Songbo, Pan Xudong, Zheng Jun, Zheng Sihong, Liu Yongmin, Sun Lizhong
Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ann Transl Med. 2022 Apr;10(7):416. doi: 10.21037/atm-22-952.
Aortic arch surgery is one of the major challenges in modern aortic surgery, special cerebral and visceral organ protective strategies are still under progress. Whether mild hypothermic circulatory arrest (Mi-HCA) can be safely used in aortic arch surgery (AAS) is the focus of attention.
From January 2017 to June 2021, a retrospective cohort study of 138 consecutive patients was conducted at Beijing Anzhen Hospital. The study comprised patients who underwent AAS performed by a single surgeon during moderate-to-mild HCA. According to the core temperature at the beginning of circulatory arrest, the patients were divided into three groups: T group (n=45; 25.76±0.75 ℃), T group (n=43; 28.79±0.81 ℃), T group (n=50; 31.46±0.79 ℃). Perioperative clinical data were analyzed to assess the differences between groups.
In this cohort, the average durations of the operation, cardiopulmonary bypass (CPB), cross-clamp, circulatory arrest, and selective antegrade cerebral perfusion (SACP) were 6.53±1.48 h, 184.07±56.69 min, 101.04±37.92 min, 23.01±9.86 min, and 27.18±11.52 min, respectively. We observed new postoperative permanent neurological dysfunction (PND) in 12 patients (8.7%) and transient neurological dysfunction in 18 patients (13.04%). The in-hospital mortality rate was 6.52% (n=9). The durations of the operation, CPB, cross-clamp, circulatory arrest, and SACP were significantly reduced in the Mi-HCA group (i.e., T group, P<0.001; P<0.001; P<0.001; P=0.002; P<0.001, respectively). The incidence of PND and major adverse events (MAEs) were significantly reduced among the three groups (P=0.025; P=0.035). Multivariate logistic regression analysis models showed that Mi-HCA was an independent protective factor in reducing postoperative MAEs [relative risk (RR) =0.12; 95% confidence interval (CI): 0.02-0.90; P=0.0385].
The short-term outcomes of Mi-HCA combined with SACP in AAS were acceptable. Similarly, the protection of distal organs and the spinal cord was observed compared to the MHCA strategy, and a lower incidence of MAEs was obtained. Current data suggest that the mild hypothermia strategy can be safely applied for AAS.
主动脉弓手术是现代主动脉手术中的主要挑战之一,特殊的脑和内脏器官保护策略仍在研究中。轻度低温循环停止(Mi-HCA)能否安全用于主动脉弓手术(AAS)是关注的焦点。
2017年1月至2021年6月,在北京安贞医院对138例连续患者进行了一项回顾性队列研究。该研究纳入了由单一外科医生在中度至轻度低温循环停止期间进行AAS的患者。根据循环停止开始时的核心温度,将患者分为三组:T1组(n = 45;25.76±0.75℃),T2组(n = 43;28.79±0.81℃),T3组(n = 50;31.46±0.79℃)。分析围手术期临床数据以评估组间差异。
在该队列中,手术、体外循环(CPB)、阻断钳夹、循环停止和选择性顺行性脑灌注(SACP)的平均持续时间分别为6.53±1.48小时、184.07±56.69分钟、101.04±37.92分钟、23.01±9.86分钟和27.18±11.52分钟。我们观察到12例患者(8.7%)出现新的术后永久性神经功能障碍(PND),18例患者(13.04%)出现短暂性神经功能障碍。住院死亡率为6.52%(n = 9)。Mi-HCA组(即T2组)的手术、CPB、阻断钳夹、循环停止和SACP的持续时间显著缩短(分别为P < 0.001;P < 0.001;P < 0.001;P = 0.002;P < 0.001)。三组间PND和主要不良事件(MAE)的发生率显著降低(P = 0.025;P = 0.035)。多因素逻辑回归分析模型显示,Mi-HCA是降低术后MAE的独立保护因素[相对危险度(RR)= 0.12;95%置信区间(CI):0.02 - 0.90;P = 0.0385]。
Mi-HCA联合SACP用于AAS的短期结果是可接受的。同样,与中度低温循环停止(MHCA)策略相比,观察到对远端器官和脊髓的保护,且MAE的发生率较低。当前数据表明,轻度低温策略可安全应用于AAS。